These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 8890046

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Serum responses to the combination of Epstein-Barr virus antigens from both latent and acute phases in nasopharyngeal carcinoma: complementary test of EBNA-1 with EA-D.
    Chow KC, Ma J, Lin LS, Chi KH, Yen SH, Liu SM, Liu WT, Chen WK, Chang TH, Chen KY.
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):363-8. PubMed ID: 9149897
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma.
    Liu MY, Chang YL, Ma J, Yang HL, Hsu MM, Chen CJ, Chen JY, Yang CS.
    J Med Virol; 1997 Jul; 52(3):262-9. PubMed ID: 9210034
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK, Fachiroh J, Artama WT, van Benthem E, Haryana SM, Middeldorp JM.
    J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT, Yeh CY.
    Radiat Med; 1998 Nov; 16(2):113-7. PubMed ID: 9650898
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic importance of heterophile antibodies and immunoglobulins IgA, IgE, IgM and low-avidity IgG against Epstein-Barr virus capsid antigen in children.
    Votava M, Bartosová D, Krchnáková A, Crhová K, Kubinová L.
    Acta Virol; 1996 Apr; 40(2):99-101. PubMed ID: 8886119
    [Abstract] [Full Text] [Related]

  • 9. Enhancing the efficiency of Epstein-Barr viral serologic test in the diagnosis of nasopharyngeal carcinoma.
    Zhang C, Zong Y, Huang B, Sun Y, Ye Y, Feng K, Li J, Zhang F.
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):356-9. PubMed ID: 12408763
    [Abstract] [Full Text] [Related]

  • 10. [Early diagnosis of nasopharyngeal carcinoma using recombinant antigens expressed in bacteria].
    Wan Z, Pi G, Sun N.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):74-6. PubMed ID: 12515179
    [Abstract] [Full Text] [Related]

  • 11. [The purification and application of Epstein-Barr virus gp125].
    Wang G, Pi G, Gu S.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):143-6. PubMed ID: 12515193
    [Abstract] [Full Text] [Related]

  • 12. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
    Karray H, Ayadi W, Fki L, Hammami A, Daoud J, Drira MM, Frikha M, Jlidi R, Middeldorp JM.
    J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
    Twu CW, Wang WY, Liang WM, Jan JS, Jiang RS, Chao J, Jin YT, Lin JC.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):130-7. PubMed ID: 16979842
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma.
    Tang JW, Rohwäder E, Chu IM, Tsang RK, Steinhagen K, Yeung AC, To KF, Chan PK.
    J Clin Virol; 2007 Dec 01; 40(4):284-8. PubMed ID: 17977062
    [Abstract] [Full Text] [Related]

  • 15. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
    Mazeron MC.
    Bull Cancer Radiother; 1996 Dec 01; 83(1):3-7. PubMed ID: 8679277
    [Abstract] [Full Text] [Related]

  • 16. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.
    Chan KH, Gu YL, Ng F, Ng PS, Seto WH, Sham JS, Chua D, Wei W, Chen YL, Luk W, Zong YS, Ng MH.
    Int J Cancer; 2003 Jul 10; 105(5):706-9. PubMed ID: 12740922
    [Abstract] [Full Text] [Related]

  • 17. Use of recombinant Epstein-Barr virus early antigen for detection of antibody in patients with nasopharyngeal carcinoma.
    Liu MT, Lin LS, Yu Y, Chung TT, Hsu CY, Chen JT, Jeng KC.
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan 10; 57(1):7-15. PubMed ID: 8820030
    [Abstract] [Full Text] [Related]

  • 18. Epstein Barr virus (EBV) antibodies in the diagnosis of NPC--comparison between IFA and two commercial ELISA kits.
    Chan SH, Soo MY, Gan YY, Fones-Tan A, Sim PS, Kaur A, Chew CT.
    Singapore Med J; 1998 Jun 10; 39(6):263-5. PubMed ID: 9803815
    [Abstract] [Full Text] [Related]

  • 19. Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection.
    Bhaduri-McIntosh S, Landry ML, Nikiforow S, Rotenberg M, El-Guindy A, Miller G.
    J Infect Dis; 2007 Feb 15; 195(4):483-92. PubMed ID: 17230407
    [Abstract] [Full Text] [Related]

  • 20. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN, Tang AZ, Zhou L, Huang GW, Wang Z, Zeng Y.
    Chin Med J (Engl); 2009 May 20; 122(10):1173-8. PubMed ID: 19493466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.